↓ Skip to main content

Pharmaceutical compounding of orphan active ingredients in Belgium: how community and hospital pharmacists can address the needs of patients with rare diseases

Overview of attention for article published in Orphanet Journal of Rare Diseases, August 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
2 X users

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
50 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Pharmaceutical compounding of orphan active ingredients in Belgium: how community and hospital pharmacists can address the needs of patients with rare diseases
Published in
Orphanet Journal of Rare Diseases, August 2019
DOI 10.1186/s13023-019-1154-x
Pubmed ID
Authors

V. Vanhoorne, E. Peeters, I. Van Tongelen, K. Boussery, E. Wynendaele, B. De Spiegeleer, J. P. Remon, C. Vervaet

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 50 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 7 14%
Other 3 6%
Student > Doctoral Student 3 6%
Student > Bachelor 2 4%
Unspecified 2 4%
Other 7 14%
Unknown 26 52%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 11 22%
Social Sciences 3 6%
Unspecified 2 4%
Business, Management and Accounting 1 2%
Nursing and Health Professions 1 2%
Other 5 10%
Unknown 27 54%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 September 2019.
All research outputs
#15,581,198
of 23,163,378 outputs
Outputs from Orphanet Journal of Rare Diseases
#1,823
of 2,654 outputs
Outputs of similar age
#213,529
of 346,880 outputs
Outputs of similar age from Orphanet Journal of Rare Diseases
#36
of 51 outputs
Altmetric has tracked 23,163,378 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,654 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one is in the 23rd percentile – i.e., 23% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 346,880 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 51 others from the same source and published within six weeks on either side of this one. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.